Related Experiment Video
Updated: Feb 7, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
ECRG4: a new potential target in precision medicine
1Medical College, Hubei University of Arts and Science, Xiangyang, 441053, China.
Abstract:
Given the rapid development in precision medicine, tremendous efforts have been devoted to discovering new biomarkers for disease diagnosis and treatment. Esophageal cancer-related gene-4 (ECRG4), which is initially known as a new candidate tumor suppressor gene, is emerging as a sentinel molecule for gauging tissue homeostasis. ECRG4 is unique in its cytokine-like functional pattern and epigenetically-regulated gene expression pattern. The gene can be released from the cell membrane upon activation and detected in liquid biopsy, thus offering considerable potential in precision medicine. This review provides an updated summary on the biology of ECRG4, with emphasis on its important roles in cancer diagnosis and therapy. The future perspectives of ECRG4 as a potential molecular marker in precision medicine are also discussed in detail.
Insights
Esophageal cancer-related gene-4 (ECRG4) shows promise as a biomarker for disease diagnosis and therapy. Its unique properties allow detection in liquid biopsies, advancing precision medicine.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Precision medicine necessitates novel biomarkers for disease detection and treatment.
- Esophageal cancer-related gene-4 (ECRG4) is recognized as a potential tumor suppressor gene.
- ECRG4 functions uniquely as a cytokine-like molecule with epigenetic regulation.
Purpose of the Study:
- To review the biology of ECRG4.
- To highlight ECRG4's roles in cancer diagnosis and therapy.
- To discuss ECRG4's future potential in precision medicine.
Main Methods:
- Literature review of ECRG4's biological functions.
- Analysis of ECRG4's role in cancer.
- Exploration of ECRG4's application in precision medicine.
Main Results:
- ECRG4 exhibits a cytokine-like pattern and epigenetic regulation.
- ECRG4 can be released from the cell membrane and detected via liquid biopsy.
- ECRG4 demonstrates significant potential in cancer diagnosis and therapeutic strategies.
Conclusions:
- ECRG4 is a promising sentinel molecule for tissue homeostasis.
- ECRG4 holds considerable potential as a biomarker in precision medicine.
- Further research into ECRG4 can enhance cancer diagnostics and therapeutics.
Related Concept Videos
Uncertainty in Measurement: Accuracy and Precision
Microorganisms in Medicine and Therapeutics
Accuracy and Precision
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Precise Definition of a Limit

